3B BlackBio Dx Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20

Sales

70.72

12.00

15.52

14.36

13.51

Operating profit

35.11

-0.93

-1.23

-1.21

-0.24

Interest

0.11

0.20

0.11

0.23

0.33

Gross profit

47.31

2.96

8.75

2.29

0.83

EPS (Rs)

39.93

2.88

10.67

2.29

0.82

Other income

12.32

4.09

10.09

3.72

1.40

Stock adjustment

0.34

-0.16

0.26

0.35

-0.05

Raw material

19.81

8.20

10.02

9.09

10.20

Power and fuel

-

-

-

-

-

Employee expenses

5.14

1.84

1.58

1.64

1.52

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

10.32

3.06

4.90

4.49

2.09

Provisions made

-

-

-

-

-

Depreciation

0.87

0.30

0.29

0.20

0.22

Taxation

12.23

0.49

0.46

0.37

-

Net profit / loss

34.21

2.16

8.01

1.72

0.61

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

8.57

7.51

7.51

7.51

7.51

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

49.64

-7.78

-7.94

-8.43

-1.77

GPM (%)

56.97

18.37

34.17

12.64

5.56

NPM (%)

41.20

13.43

31.26

9.50

4.12